The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
β Scribed by Farina-Sarasqueta, A.; van Lijnschoten, G.; Moerland, E.; Creemers, G.- J.; Lemmens, V. E. P. P.; Rutten, H. J. T.; van den Brule, A. J. C.
- Book ID
- 127313463
- Publisher
- Oxford University Press
- Year
- 2010
- Tongue
- English
- Weight
- 199 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0923-7534
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co
## Abstract ## BACKGROUND The elucidation of new therapeutic targets of prognostic significance in colon carcinoma is necessary to improve outcomes. In the current study, the authors examined the expression of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) in